You just read:

Cellenkos Inc. Focuses on the Development of Cell-Therapy for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)

News provided by

Cellenkos, Inc.

Mar 17, 2020, 10:17 ET